Preclinical Study of (68)Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs

OBJECTIVE(S): Gallium-68 DOTA-DPhe(1)-Tyr(3)-Octreotide ((68)Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderi, Mojdeh, Zolghadri, Samaneh, Yousefnia, Hassan, Ramazani, Ali, Jalilian, Amir Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Oceania Journal of Nuclear Medicine & Biology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937676/
https://www.ncbi.nlm.nih.gov/pubmed/27904870
http://dx.doi.org/10.7508/aojnmb.2016.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937676/
https://www.ncbi.nlm.nih.gov/pubmed/27904870
http://dx.doi.org/10.7508/aojnmb.2016.04.004

Ejemplares similares